Biopsy frequency and complications among lung cancer patients in the United States

OBJECTIVE: This study aimed to describe the frequency and distribution of biopsy procedures for patients diagnosed and treated for primary lung cancer. STUDY DESIGN: Retrospective cohort study within an administrative database. MATERIALS & METHODS: This observational study used data from the IBM...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yichen, Shi, Lizheng, Simoff, Michael J, J Wagner, Oliver, Lavin, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729592/
https://www.ncbi.nlm.nih.gov/pubmed/33318758
http://dx.doi.org/10.2217/lmt-2020-0022
Descripción
Sumario:OBJECTIVE: This study aimed to describe the frequency and distribution of biopsy procedures for patients diagnosed and treated for primary lung cancer. STUDY DESIGN: Retrospective cohort study within an administrative database. MATERIALS & METHODS: This observational study used data from the IBM MarketScan(®) Databases between 2013 and 2015. RESULTS: The total number of lung biopsies performed among eligible subjects was 32,814; an average of 1.7 biopsies per patient. Bronchoscopy and percutaneous approaches accounted for 95% of all procedures. Complication rates by procedure are remarkably similar irrespective of biopsy frequency. CONCLUSION: Nearly half (46%) of patients in this population experienced multiple biopsies prior to diagnosis. Further, biopsy choice or sequence in patients receiving multiple procedures was unpredictable.

Ejemplares similares